Medtronic disclosed that the Food and Drug Administration approved Simplera, the medical technology company's continuous glucose monitor. The Dublin-based company said its Simplera platform ...

Medtronic MDT recently announced two major developments within its diabetes care business. The company received FDA approval for its Simplera continuous glucose monitor (CGM), which marks a ...

Abbott has entered a global partnership focusing on the integration of its advanced FreeStyle Libre continuous glucose ...

Medtronic plc hit a sweet spot with its diabetes devices ... but even the microneedles used in current continuous glucose systems.

Unique partnership with Medtronic will enable continuous glucose monitoring (CGM) sensors based on Abbott's FreeStyle Libre sensing technology to integrate with Medtronic's insulin delivery ...

Senseonics, a medtech manufacturer developing long-term, implantable continuous glucose monitoring (CGM) systems, and ...

Medtronic (NYSE: MDT ... Notably, the FDA cleared Simplera, a disposable all-in-one continuous glucose monitor (CGM) that works with the MiniMed 780G. The larger Cardiovascular business has ...

Medtronic may be an underrated beneficiary of declining interest rates. That's because as rates come down, it becomes less ...

Medtronic faced challenges ... from pod-based insulin delivery with no pumps or needles and continuous glucose monitoring (“CGM”), impacted sales. The firm's recent product approval of ...

Medtronic (NYSE: MDT ... From catheters to neurostimulators to continuous glucose monitoring devices, the company has a broad range of products in its portfolio, and it's routinely coming out ...